Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anouk Dev

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Respirology (Carlton, Vic.)|February 8, 2020
Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New ZealandJack Dummer, Claudia C Dobler, Mark Holmes, et al.
Journal of Translational Medicine|July 13, 2007
Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infectionIan R White, Keyur Patel, William T Symonds, et al.
The American Journal of Pathology|March 24, 2020
Constitutive STAT3 Serine Phosphorylation Promotes Helicobacter-Mediated Gastric DiseaseJesse J Balic, Mohamed I Saad, Ruby Dawson, et al.
Hepatology (Baltimore, Md.)|October 6, 2015
Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is neededThai P Hong, Paul Gow, Michael Fink, et al.
The Journal of Pathology|June 29, 2011
The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17Catherine L Kennedy, Meri Najdovska, Gareth W Jones, et al.
Cancer Cell|October 20, 2012
STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammationHazel Tye, Catherine L Kennedy, Meri Najdovska, et al.
The Medical Journal of Australia|October 13, 2018
Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based studyThai P Hong, Paul J Gow, Michael Fink, et al.
Journal of Gastroenterology and Hepatology|January 11, 2013
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-αJacinta A Holmes, Tin Nguyen, Dilip Ratnam, et al.
Scandinavian Journal of Gastroenterology|May 11, 2016
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world studyAdam Doyle, Philip Marsh, Raghubinder Gill, et al.
Internal Medicine Journal|November 2, 2018
Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohortPoornima Varma, Anton S Rajadurai, Darcy Q Holt, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Respirology (Carlton, Vic.)|February 8, 2020
Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New ZealandJack Dummer, Claudia C Dobler, Mark Holmes, et al.
Journal of Translational Medicine|July 13, 2007
Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infectionIan R White, Keyur Patel, William T Symonds, et al.
The American Journal of Pathology|March 24, 2020
Constitutive STAT3 Serine Phosphorylation Promotes Helicobacter-Mediated Gastric DiseaseJesse J Balic, Mohamed I Saad, Ruby Dawson, et al.
Hepatology (Baltimore, Md.)|October 6, 2015
Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is neededThai P Hong, Paul Gow, Michael Fink, et al.
The Journal of Pathology|June 29, 2011
The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17Catherine L Kennedy, Meri Najdovska, Gareth W Jones, et al.
Cancer Cell|October 20, 2012
STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammationHazel Tye, Catherine L Kennedy, Meri Najdovska, et al.
The Medical Journal of Australia|October 13, 2018
Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based studyThai P Hong, Paul J Gow, Michael Fink, et al.
Journal of Gastroenterology and Hepatology|January 11, 2013
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-αJacinta A Holmes, Tin Nguyen, Dilip Ratnam, et al.
Scandinavian Journal of Gastroenterology|May 11, 2016
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world studyAdam Doyle, Philip Marsh, Raghubinder Gill, et al.
Internal Medicine Journal|November 2, 2018
Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohortPoornima Varma, Anton S Rajadurai, Darcy Q Holt, et al.
Pageof 7